Skip to main content
SpringerLink
Log in

Differential effects of nifedipine, verapamil, and diltiazem on noradrenaline-induced contractions, adrenergic transmitter release, and alpha-adrenoceptor binding in the female rabbit urethra

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

In order to study differences in action between “Ca2+-entry blockers” on smooth muscle and peripheral nerves, the effects of nifedipine, verapamil, and diltiazem on noradrenaline (NA)-induced contractions and electrically evoked release of 3H-NA were investigated in the female rabbit urethra. In addition, possible influences of Ca2+-entry blockers on alpha-adrenoceptors were studied with radioligand binding technique. Exposure to Ca2+-free medium completely abolished the contractile response to 1 μM NA in the rabbit urethra, indicating that the contraction was entirely dependent on influx of extracellular Ca2+. The Ca2+-entry blockers inhibited the NA-induced contractions in the following order of potency: nifedipine>verapamil≈diltiazem. In contrast to nifedipine and diltiazem, which produced a maximum inhibition of between 50 and 60%, verapamil was able to abolish the contractile responses to NA. The electrically evoked efflux of 3H-NA was decreased by diltiazem and increased by verapamil, whereas nifedipine failed to alter the 3H-NA efflux. Only verapamil was effective in inhibiting specific 3H-DHE binding to a crude membrane preparation of the rabbit bladder base and urethra, and the inhibition appeared to be of the competitive type. It is suggested that the effects of verapamil on electrically evoked efflux of 3H-NA and on NA-induced contractions can be partly explained by blockade of pre- and post-junctional alpha-adrenoceptors. The failure of nifedipine and diltiazem to abolish the NA-induced contraction might indicate the existence of different Ca2+-entry pathways in urethral smooth muscle.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andersson K-E, Högestätt ED (1984) On the mechanism of action of calcium antagonists. Acta Med Scand Suppl 68:11–24

    Google Scholar 

  • Andersson K-E, Larsson B, Sjögren C (1984) Characterization of the α-adrenoceptors in the female rabbit urethra. Br J Pharmacol 81:293–300

    Google Scholar 

  • Antman EM, Stone PH, Muller JE, Braunwald E (1980) Calcium channel blocking agents in the treatment of cardiovascular disorders. I. Basic and clinical electrophysiologic effects. Ann Intern Med 93:875–885

    Google Scholar 

  • Barnathan ES, Addonizio VP, Shattil SJ (1982) Interaction of verapamil with human platelet α-adrenergic receptors. Am J Physiol 242:H19-H23

    Google Scholar 

  • Bayer R, Ehara T (1978) Comparative studies on calcium antagonists. Prog Pharmacol 2:31–37

    Google Scholar 

  • Bayer R, Kalusche D, Kaufmann R, Mannhold R (1975) Inotropic and electrophysiological actions of verapamil and D600 in mammalian myocardium. III. Effects of the optical isomers on transmembrane action potentials. Naunyn-Schmiedeberg's Arch Pharmacol 290:81–97

    Google Scholar 

  • Bellemann P, Ferry D, Lübbecke F, Glossmann H (1982) 3H-Nimodipine and 3H-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Arzneimittelforsch 32:361–363

    Google Scholar 

  • Benson GS, Jacobowitz D, Raezer DM, Corriere JN Jr, Wein AJ (1976) Adrenergic innervation and stimulation of canine urethra. Urology 7:337–340

    Google Scholar 

  • Blackmore PF, El-Refai MF, Exton JH (1979) α-Adrenergic blockade and inhibition of A23187 mediated Ca2+ uptake by the calcium antagonist verapamil in rat liver cells. Mol Pharmacol 15:598–606

    Google Scholar 

  • Bliss CI (1967) Statistics in biology, vol 1. McGraw-Hill, New York St Louis San Francisco Toronto London Sydney

    Google Scholar 

  • Bolton TB (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59:606–718

    Google Scholar 

  • Cheng Y-C, Prusoff WH (1973) Relationship between the inhibition constant (K 1) and the concentration of inhibitor which cause 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108

    Google Scholar 

  • Church J, Zsotér TT (1980) Calcium antagonistic drugs. Mechanism of action. Can J Physiol Pharmacol 58:254–264

    Google Scholar 

  • DePover A, Matlib MA, Lee SW, Dubé GP, Grupp IL, Grupp G, Schwartz A (1982) Specific binding of [3H] nitrendipine to membranes from coronary arteries and heart in relation to pharmacological effects. Paradoxical stimulation by diltiazem. Biochem Biophys Res Commun 108:110–117

    Google Scholar 

  • Ebstein RP, Daly JW (1982) Release of norepinephrine and dopamine from brain vesicular preparations: Effects of calcium antagonists. Cell Mol Neurobiol 2:205–213

    Google Scholar 

  • Ehlert FJ, Roeske WR, Itoga E, Yamamura HI (1982) The binding of [3H] nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats. Life Sci 30: 2191–2202

    Google Scholar 

  • Ellrodt G, Chew CYC, Singh BN (1980) Therapeutic implications of slow-channel blockade in cardiocirculatory disorders. Circulation 62:669–679

    Google Scholar 

  • Fairhurst AS, Whittaker ML, Ehlert FJ (1980) Interactions of D 600 (Methoxyverapamil) and local anesthetics with rat brain α-adrenergic and muscarinic receptors. Biochem Pharmacol 29:155–162

    Google Scholar 

  • Ferry DR, Glossmann H (1982) Evidence for multiple receptor sites within the putative calcium channel. Naunyn-Schmiedeberg's Arch Pharmacol 321:80–83

    Google Scholar 

  • Fleckenstein A (1977) Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann Rev Pharmacol Toxicol 17:149–166

    Google Scholar 

  • Galper JB, Catterall WA (1979) Inhibition of sodium channels by D 600. Mol Pharmacol 15:174–178

    Google Scholar 

  • Galzin A-M, Langer SZ (1983) Presynaptic α2-adrenoceptor antagonism by verapamil but not by diltiazem in rabbit hypothalamic slices. Br J Pharmacol 78:571–577

    Google Scholar 

  • Glossman H, Hornung R (1980) Calcium- and potassium-channel blockers interact with α-adrenoceptors. Mol Cell Endocrinol 19:243–251

    Google Scholar 

  • Glossmann H, Ferry DR, Lübbecke F, Mewes R, Hofmann F (1982) Calcium channels: direct identification with radioligand binding studies. Trends Pharmacol Sci 3:431–437

    Google Scholar 

  • Hagiwara S, Byerly L (1981) Calcium channel. Ann Rev Neurosci 4:69–125

    Google Scholar 

  • Henry PD (1980) Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol 46: 1047–1058

    Google Scholar 

  • Holek M, Thorens S, Haeusler G (1982) Characterization of [3H] nifedipine binding sites in rabbit myocardium. Eur J Pharmacol 85:305–315

    Google Scholar 

  • Högestätt ED, Andersson K-E, Edvinsson L (1982) Effects of nifedipine on potassium-induced contraction and noradrenaline release in cerebral and extracranial arteries from rabbit. Acta Physiol Scand 114:283–296

    Google Scholar 

  • Högestätt ED, Andersson K-E, Edvinsson L (1983) Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand 117:49–61

    Google Scholar 

  • Jim K, Harris A, Rosenberger LB, Triggle DJ (1981) Stereoselective and non-stereoselective effects of D600 (methoxyverapamil) in smooth muscle preparations. Eur J Pharmacol 76:67–72

    Google Scholar 

  • Kajiwara M, Casteels R (1983) Effects of Ca-antagonists on neuromuscular transmission in the rabbit ear artery. Pflügers Arch 396:1–7

    Google Scholar 

  • Kaplita PV, Triggle DJ (1983) Actions of Ca2+ antagonists on the guinea-pig ileal myenteric plexus preparation. Biochem Pharmacol 32:65–68

    Google Scholar 

  • Karliner JS, Motulsky HJ, Dunlap J, Heller Brown J, Insel PA (1982) Verapamil competitively inhibits α1-adrenergic and muscarinic but not β-adrenergic receptors in rat myocardium. J Cardiovasc Pharmacol 4:515–520

    Google Scholar 

  • Kohlhardt M, Fleckenstein A (1977) Inhibition of the slow inward current by nifedipine in mammalian ventricular myocardium. Naunyn-Schmiedeberg's Arch Pharmacol 298:267–272

    Google Scholar 

  • Kondo K, Suzuki H, Okuno T, Suda M, Satura T (1980) Effects of nifedipine, diltiazem and verapamil on the vasoconstrictor responses to norepinephrine and potassium ions in the rat mesenteric artery. Arch Int Pharmacodyn Ther 245:211–217

    Google Scholar 

  • Larsson B (1983) Demonstration of α-adrenoceptors in the rabbit bladder base and urethra with 3H-dihydroergocryptine ligand binding. Acta Pharmacol Toxicol 52:188–194

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  • Marangos PJ, Patel J, Miller C, Martino AM (1982) Specific calcium antagonist binding sites in brain. Life Sci 31:1575–1585

    Google Scholar 

  • McDonald TF, Pelzer D, Trautwein W (1980) On the mechanism of slow calcium channel block in heart. Pflügers Arch 385:175–179

    Google Scholar 

  • Meel JCA van, Jonge A de, Kalkman HO, Wilffert B, Timmermanns PBMWM, Zwieten PA van (1981) Organic and inorganic calcium antagonists reduce vasoconstriction in vivo mediated by postsynaptic α2-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 316:288–293

    Google Scholar 

  • Mikkelsen E, Andersson K-E, Lederballe Pedersen O (1979) Verapamil and nifedipine inhibition of contractions induced by potassium and noradrenaline in human mesenteric arteries and veins. Acta Pharmacol Toxicol 44:110–119

    Google Scholar 

  • Motulsky HJ, Snavely MD, Hughes RJ, Insel PA (1983) Interaction of verapamil and other calcium channel blockers with α1- and α2-adrenergic receptors. Circ Res 52:226–231

    Google Scholar 

  • Murphy KMM, Snyder SH (1982) Calcium antagonist receptor binding sites labeled with [3H] nitrendipine. Eur J Pharmacol 77:201–202

    Google Scholar 

  • Nachshen DA, Blaustein MP (1979) The effects of some organic “calcium antagonists” on calcium influx in presynaptic nerve terminals. Mol Pharmacol 16:579–586

    Google Scholar 

  • Nawrath H, Ten Eick RE, McDonald TF, Trautwein W (1977) On the mechanism underlying the action of D-600 on slow inward current and tension in mammalian myocardium. Circ Res 40:408–414

    Google Scholar 

  • Nayler WG, Poole-Wilson Ph (1981) Calcium antagonists: definition and mode of action. Basic Res Cardiol 76:1–15

    Google Scholar 

  • Nayler WG, Thompson JE, Jarrott B (1982) The interaction of calcium antagonists (slow channel blockers) with myocardial alpha adrenoceptors. J Mol Cell Cardiol 14:185–188

    Google Scholar 

  • Owman C, Owman T, Sjöberg N-O (1971) Short adrenergic neurones innervating the female urethra of the cat. Experientia 27:313–315

    Google Scholar 

  • Reuter H (1979) Properties of two inward membrane currents in the heart. Ann Rev Physiol 41:413–424

    Google Scholar 

  • Starke K, Schümann HJ (1973) Wirkung von Nifedipine auf die Funktion der sympathischen Nerven des Herzen. Arzneimittelforsch 23:193–197

    Google Scholar 

  • Stone PH, Antman EM, Muller JE, Braunwald E (1980) Calcium channel blocking agents in the treatment of cardiovascular disorders. II. Hemodynamic effects and clinical applications. Ann Intern Med 93:886–904

    Google Scholar 

  • Triggle DJ (1981) Calcium antagonists: Basic chemical and pharmacological aspects. In: Weiss GB (ed) New perspectives on calcium antagonists. American Physiological Society, Bethesda, pp 1–18

    Google Scholar 

  • Williams LT, Lefkowitz RJ (1977) Molecular pharmacology of alpha adrenergic receptors: utilization of [3H] dihydroergocryptine binding in the study of pharmacological receptor alterations. Mol Pharmacol 13:304–313

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, University Hospital of Lund, S-22185, Lund, Sweden

    B. Larsson, E. D. Högestätt, A. Mattiasson & K. -E. Andersson

Authors
  1. B. Larsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. D. Högestätt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Mattiasson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. -E. Andersson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Larsson, B., Högestätt, E.D., Mattiasson, A. et al. Differential effects of nifedipine, verapamil, and diltiazem on noradrenaline-induced contractions, adrenergic transmitter release, and alpha-adrenoceptor binding in the female rabbit urethra. Naunyn-Schmiedeberg's Arch. Pharmacol. 326, 14–21 (1984). https://doi.org/10.1007/BF00518773

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00518773

Key words

Search

Navigation